130953-69-4 Usage
Originator
Besipirdine,Hoechst-Roussel
Manufacturing Process
Part A: N-Propyl-N-(4-pyridinyl)-1H-indol-1-amine maleate:
A solution of N-(4-pyridinyl)-1H-indol-1-amine (6 g) in 25 ml of
dimethylformamide was slowly added to an ice-cooled suspension of NaH (1.3
g of 60% NaH dispersion in mineral oil was washed with hexanes, the liquid
was decanted and the residual solid was dispersed in 5 ml of
dimethylformamide). After anion formation, a solution of 1-bromopropane (4
g) in 5 ml of dimethylformamide was added. After one hour of stirring at
ambient temperature, the reaction mixture was stirred with ice-water and
extracted with dichloromethane. The organic extract was washed with water
and saturated sodium chloride solution, was dried over anhydrous magnesium
sulfate, filtered and concentrated to 8 g of oil. This oil was purified by HPLC
(silica, ethyl acetate) and thereafter by column chromatography (alumina,
ether) to give 6.4 g oil. This oil was converted to the maleate salt and
recrystallized from methanol/ether to give 6.8 g of crystals, m.p. 115-116°C.
Part B: N-Propyl-N-(4-pyridinyl)-1H-indol-1-amine hydrochloride:
N-Propyl-N-(4-pyridinyl)-1H-indol-1-amine maleate was converted to the free
base by action of alcaline agent. Then the free base oil was converted to the
hydrochloride salt which was recrystallized from methanol; m.p. 212-214°C.
Therapeutic Function
Cognition activator
Check Digit Verification of cas no
The CAS Registry Mumber 130953-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,9,5 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 130953-69:
(8*1)+(7*3)+(6*0)+(5*9)+(4*5)+(3*3)+(2*6)+(1*9)=124
124 % 10 = 4
So 130953-69-4 is a valid CAS Registry Number.
InChI:InChI=1/C16H17N3.ClH/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19;/h3-11,13H,2,12H2,1H3;1H
130953-69-4Relevant articles and documents
USE OF UNSUBSTITUTED AND SUBSTITUTED N-(PYRROL-1-YL)PYRIDINAMINES AS ANTICONVULSANT AGENTS
-
, (2008/06/13)
This invention relates to a method of treating a patient in need of relief from convulsions which comprises administering to such a patient a convulsion-alleviating amount of a compound of formula (I), wherein R, R, R, R, R, m and n are as def
Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
-
, (2008/06/13)
There is disclosed a method of alleviating obsessive compulsive disorders which comprises administration of an effective amount of a compound of the formula. STR1 where m is 1 or 2; R is H, halogen, loweralkyl, loweralkoxy, arylloweralkoxy, hydroxy, nitro, amino, loweralkylamino or diloweralkylamino; R1 is H or loweralkyl; R2 is H or loweralkyl; and R3 is H, halogen or loweralkyl.